In Conversation with Matt Dolan

As a senior research analyst focused on medical technology: (devices and diagnostics) with ROTH Capital Partners, Matt Dolan’s investment views have been cited by a “Who’s Who” of publications on Wall Street. Prior to joining Roth in 2003, Mr. Dolan, a graduate of Northwestern University, formed a trading group at the Chicago Board of Trade [...]

TearLab Osmolarity System gets CLIA Waiver from FDA

The FDA has granted a waiver categorization under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for the TearLab (NASDAQ:TEAR; TSX:TLB) Osmolarity System. The FDA took the action after reviewing and accepting labeling submitted to it by TearLab. “We believe that, with CLIA Waiver and Medicare reimbursement in place, and with the updated American Academy [...]

CMS approves TearLab’s reconsideration request

The Centers for Medicare and Medicaid Services (CMS) has published instructions for updates to the clinical laboratory fee schedule for 2012, including a revised reimbursement rate for the TearLab (NASDAQ:TEAR; TSX:TLB) Osmolarity Test, effective Jan. 1. The payment code of 83861 that currently applies to the TearLab test for diagnosing Dry Eye Disease will be [...]

Roth ups TearLab price target to $3

Roth Capital Partners has raised its price target on “buy-rated” TearLab (NASDAQ:TEAR; TSX:TLB) to $3 from $2.20, citing a decision by the FDA to grant the TearLab Osmolarity System a waiver under the Clinical Laboratory Improvement Amendments (CLIA). The stock was quoted at $1.19 Tuesday afternoon. “This milestone could represent a significant driver of TearLab [...]

TearLab taps social media for dry eye awareness

During the past six months, TearLab (NASDAQ:TEAR;TSX:TLB) has initiated a series of social media campaigns as part of an innovative strategy to increase the awareness of dry eye disease (DED) with both patients and doctors. The program is also designed to demonstrate how its diagnostic test for dry eye can change the paradigm of dry [...]

FDA grants CLIA-waiver for TearLab osmolarity test

The FDA has advised TearLab (NASDAQ:TEAR; TSX:TLB) that based on a supervisory review of the company’s appeal, the agency has granted its petition for a waiver under the Clinical Laboratory Improvement Amendments (CLIA) for the TearLab Osmolarity System. After the company’s submission of labelling acceptable to the agency, the CLIA-waiver will be issued. “This marks [...]

Roth starts TearLab at buy

Roth Capital Partners has initiated coverage of TearLab (NASDAQ:TEAR; TSX:TLB) with the “buy” rating and 12-month price target of $2.20. The stock was quoted at $1.42, up 12%, Thursday morning. Analyst Matt Dolan writes that he expects company’s sales to “ramp steadily over the next several quarters, with the potential for a more substantial acceleration [...]

TearLab to present at Piper Jaffray Healthcare Conference

TearLab (NASDAQ:TEAR; TSX:TLB) CEO Elias Vamvakas will present an update on the company’s business at the 23rd annual Piper Jaffray Healthcare Conference in New York this morning. Mr. Vamvakas’ presentation will be webcast live and archived for at least 30 days on the company’s website at www.tearlab.com under the “Webcasts” tab in the Investors section. [...]

Data released on impact of tear osmolarity on Lasik outcomes

Data has been presented at the European Society of Cataract and Refractive Surgeons Annual Congress in Vienna from a multi-site refractive surgery center study designed to determine how pre- and post-Lasik tear osmolarity levels relate to rates of Dry Eye Disease (DED) and DED symptoms. TearLab (NASDAQ:TEAR; TSX:TLB) osmolarity testing, OSDI symptomology, as well as [...]

Seasoned international eye care professional, Richard Lee, joins TearLab

Richard Lee has been appointed EMEA business development director of TearLab (NASDAQ:TEAR; TSX:TLB) to oversee sales, marketing, operations and customer service activities for Europe, the Middle East and Africa. TearLab Reader Mr. Lee most recently was a consultant, helping develop the market for the TearLab Osmolarity System in the U.K. He also has held EMEA [...]

Next Page »